MUMBAI, India--(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. announced that together with its affiliates (“Sun Pharma”) it has executed a settlement agreement with Orion stipulating a dismissal of the lawsuits filed in the United States against Sun Pharma regarding submission of Abbreviated New Drug Applications (ANDAs) for generic versions of Stalevo® and Comtan® tablets.
